Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Depreciation and Depletion: 2011-2025

Historic Depreciation and Depletion for Aytu Biopharma (AYTU) over the last 13 years, with Jun 2025 value amounting to $200,000.

  • Aytu Biopharma's Depreciation and Depletion changed negligibly% to $100,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $400,000, marking a year-over-year decrease of 42.86%. This contributed to the annual value of $200,000 for FY2025, which is 77.78% down from last year.
  • Latest data reveals that Aytu Biopharma reported Depreciation and Depletion of $200,000 as of FY2025, which was down 77.78% from $900,000 recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Depreciation and Depletion registered a high of $1.6 million during FY2022, and its lowest value of $200,000 during FY2025.
  • For the 3-year period, Aytu Biopharma's Depreciation and Depletion averaged around $800,000, with its median value being $900,000 (2024).
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first spiked by 500.00% in 2021, then tumbled by 77.78% in 2025.
  • Aytu Biopharma's Depreciation and Depletion (Yearly) stood at $600,000 in 2021, then surged by 166.67% to $1.6 million in 2022, then fell by 18.75% to $1.3 million in 2023, then tumbled by 30.77% to $900,000 in 2024, then crashed by 77.78% to $200,000 in 2025.